Holograms and Metabolomics: Inside the Desai Sethi Urology Institute

The defining characteristic of a world-class academic medical center is its ability to turn immense clinical volume into a laboratory for translational science. Following a series of landmark presentations at the American Urological Association (AUA) 2026 annual meeting, the Desai Sethi Urology Institute (DSUI) at the University of Miami Miller School of Medicine has solidified its position as a premier national proving ground for surgical artificial intelligence and spatial computing. This clinical leap forward is a direct extension of the university's broader XR Initiative, which since 2018 has pioneered the use of immersive technology to solve complex problems. Rather than treating technology as a futuristic concept, DSUI has integrated deep-learning algorithms, real-time metabolomics, and the urologic metaverse directly into the continuum of localized patient care.

Surgical AI and autonomous instrumentation require vast, diverse pools of data to achieve predictive accuracy. Miami provides this foundational data engine through its dominant regional footprint, handling 40% of all urologic surgeries and 65% of all bladder cancer surgeries across Miami-Dade County. To maximize this volume, researchers like Dr. Jonathan Katz are developing autonomous tools, such as an autonomous ureteroscope for kidney stone removal, using simulations to generate synthetic data for model training and validation. By utilizing these high-level computational engineering frameworks, Miami is transforming raw clinical volume into highly precise, self-learning healthcare models.

The institute’s operational philosophy also relies on a frictionless pipeline connecting the operating room directly to advanced laboratory benches. Guided by Scientific Director Dr. Nima Sharifi, this translational protocol was recently spotlighted by urologic oncology fellow Dr. Pedro Freitas in a one-of-a-kind renal cell carcinoma study. The protocol captures a pristine "molecular snapshot" of a tumor's microenvironment by extracting selective blood samples directly from renal arteries and veins immediately prior to organ removal. The samples are routed to DSUI’s laboratory infrastructure, where advanced profiling maps distinct cellular metabolites. By pairing a tumor's structural boundaries with its exact chemical signature, clinicians can identify biomarkers for tumor aggressiveness under active surgical conditions.

This technological evolution culminates in surgeon-centered spatial computing, fulfilling the university’s institutional vision where the internet and medical practice become truly immersive. Overcoming the limitations of traditional fusion biopsies, which force surgeons to look away from the patient at flat, 2D screens, Dr. Archan Khandekar’s integration of the Microsoft HoloLens platform brings 3D tumor visualization directly into the surgical line of sight. Using upstream artificial intelligence, multiparametric MRI (mpMRI) datasets are analyzed by habitat risk-scoring algorithms that automatically segment suspicious lesions. The AR platform then projects these high-fidelity 3D holographic overlaysdirectly onto the target organ through optical tracking, allowing the surgeon to see the lesion floating exactly where it lies within the tissue and map the precise needle trajectory prior to puncture.

This digital vanguard is balanced by an institutional commitment to elite physical training and shared clinical mastery. Under the leadership of Dr. Mark Gonzalgo, Professor and Chair of Urology, and faculty educators like Dr. Laura Horodyski, the institute ensures its high-tech infrastructure is matched by flawless surgical execution. Because the HoloLens platform's high-fidelity navigation allows the entire team to view the holographic overlay simultaneously, complex procedures are turned into collaborative, shared training environments within a virtual clinical ecosystem.

With its AUA milestones established, DSUI’s trajectory shifts to national standardization. Dr. Khandekar’s team is currently leveraging advanced sixth-generation trackers to eliminate minor positional artifacts and accuracy drift caused by soft-tissue deformation during live procedures. Concurrently, by breaking down traditional departmental silos and uniting engineers, clinicians, and basic scientists under one roof, Miami is uniquely positioned to establish the safety, efficiency, and peer-validated benchmarks for the next era of global surgical medicine.